Cathie's Ark Logo
Invitae Corp Logo

ARKK Holdings of Invitae Corporation (NVTA) - Updated Daily

BioinformaticsGenetic Testing
Date
Direction
Shares
Fund Weight
Fund
August 24, 2023
BUY886.062k0.0103%ARKK
June 16, 2023
BUY333.362k0.0051%ARKK
May 11, 2023
BUY300.807k0.0059%ARKK
May 10, 2023
BUY173.756k0.0034%ARKK
May 3, 2023
BUY58.992k0.0012%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
0.18%$168.17m
🏋🏿‍♂️Weight Rank In ARKK🌏Country
31🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
81$12.24
🎫ARK Ownership Percent
7.07%
Description
invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. specializing in genetic diagnostics for hereditary disorders, invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. choose from our curated panels or design your own test for the same low price. today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. together we can improve healthcare for billions of people.
Website
https://www.invitae.com

Other ETFs That Hold NVTA

Ticker
NameWeight
ARKGARK Genomic Revolution ETF0.6%
GNOMGlobal X Genomics & Biotechnology ETF0.57%
ARKKARK Innovation ETF0.35%
IBBiShares Biotechnology ETF0.05%

Research Notes and Commentary for NVTA

No Research Notes Found for NVTA